- Home
- CYD vs RLAY Comparison
CYD vs RLAY Comparison
Compare CYD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYD
- RLAY
- Stock Information
- Founded
- CYD 1951
- RLAY 2015
- Country
- CYD Singapore
- RLAY United States
- Employees
- CYD N/A
- RLAY N/A
- Industry
- CYD Industrial Machinery/Components
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CYD Industrials
- RLAY Health Care
- Exchange
- CYD Nasdaq
- RLAY Nasdaq
- Market Cap
- CYD 609.7M
- RLAY 619.0M
- IPO Year
- CYD 1994
- RLAY 2020
- Fundamental
- Price
- CYD $38.24
- RLAY $4.40
- Analyst Decision
- CYD
- RLAY Strong Buy
- Analyst Count
- CYD 0
- RLAY 13
- Target Price
- CYD N/A
- RLAY $18.00
- AVG Volume (30 Days)
- CYD 267.4K
- RLAY 1.2M
- Earning Date
- CYD 08-08-2025
- RLAY 11-05-2025
- Dividend Yield
- CYD 1.29%
- RLAY N/A
- EPS Growth
- CYD 40.10
- RLAY N/A
- EPS
- CYD 1.66
- RLAY N/A
- Revenue
- CYD $3,159,401,156.00
- RLAY $8,355,000.00
- Revenue This Year
- CYD $6.43
- RLAY $31.55
- Revenue Next Year
- CYD $11.20
- RLAY N/A
- P/E Ratio
- CYD $24.31
- RLAY N/A
- Revenue Growth
- CYD 17.99
- RLAY N/A
- 52 Week Low
- CYD $8.61
- RLAY $1.78
- 52 Week High
- CYD $41.39
- RLAY $8.19
- Technical
- Relative Strength Index (RSI)
- CYD 70.10
- RLAY 69.03
- Support Level
- CYD $32.71
- RLAY $4.05
- Resistance Level
- CYD $33.87
- RLAY $4.34
- Average True Range (ATR)
- CYD 1.74
- RLAY 0.25
- MACD
- CYD 0.30
- RLAY 0.03
- Stochastic Oscillator
- CYD 73.70
- RLAY 89.80
About CYD China Yuchai International Limited
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).